Ford, Clayton

USPTO Trademark & Patent Filings

Ford John

Trademark applications and grants for Ford, Clayton. Ford, Clayton has 17 trademark applications. The latest application filed is for "a symbol or image mark"

Company Profile
    Company Aliases
  • Ford, John
  • John Ford
  • john ford
  • FORD; John - Madison TN
  • FORD; John - Cambridgeshire GB
  • Ford; John - Atlanta GA
  • Ford; John - Madison TN
  • Ford; John - Cambridgeshire GB
State Incorporated
Entity Type
Address 13115 Natural Streps Dr Roland, ARKANSAS UNITED STATES 72135

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents
Patent Applications
Patent ApplicationDate
SHIELDING FACILITY AND METHODS OFMAKING THEREOF
20210383938 - 17/322726 FORD; John ;   et al.
2021-12-09
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
20210228580 - 17/226655 FORD; John ;   et al.
2021-07-29
ADAPTIVE SIGNALING FOR NETWORK PERFORMANCE MEASUREMENT, ACCESS, AND CONTROL
20210227033 - 16/086534 Augenstine; Jonathan ;   et al.
2021-07-22
SHIELDING FACILITY AND METHODS OFMAKING THEREOF
20210098147 - 17/097915 FORD; John ;   et al.
2021-04-01
Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Tre
20200230138 - FORD; John ;   et al.
2020-07-23
Shielding facility and methods of making thereof
11,437,160 - 17/097,915 Ford , et al. September 6, 2
2022-09-06
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
11,013,742 - 16/844,996 Ford , et al. May 25, 2
2021-05-25
Shielding facility and method of making thereof
10,878,974 - 16/713,843 Ford , et al. December 29, 2
2020-12-29
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
10,653,692 - 15/117,154 Ford , et al.
2020-05-19
Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors
10,300,059 - 15/507,669 Ford , et al.
2019-05-28
Patent Grants & Applications
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed